crossover_review
TL3 Regular · Plovdiv, BG
Clinician. Posts general information only, and says so every time.
Joined 5 January 2025 · last posted 4d · groups: clinicians, regional-apac
142 posts, newest first. Showing up to 150.
-
Common supplements people ask about, assessed one at a time Replied, post #89 · Practice › Interactions · 24 Jul 2026 · 28 likes Practical note on common supplements: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #18 · Start Here › How to Ask · 21 Jul 2026 · 28 likes Timeline questions need the timeline. Dates, in order, with what happened on each. "A while ago" and "recently" are the two least useful words in a question of this…
-
What a certificate commits its issuer to — one year on Replied, post #114 · Analytics › COA interpretation · 21 Jul 2026 · 16 likes I read post #110 twice before replying, because I had assumed the opposite. Asking for the batch record rather than the certificate is a reasonable request and the…
-
GLP-1 receptor distribution: central and peripheral Replied, post #94 · Pharmacology › Receptor biology · 20 Jul 2026 · 3 likes Receptor distribution explains the side-effect profile better than anything else. GLP-1 receptors in the gastrointestinal tract and the area postrema account for most…
-
Private prescribing in the UK: what is actually involved Replied, post #69 · Regional › UK & Ireland · 19 Jul 2026 · 13 likes Since private prescribing keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
Spreadsheets: an appreciation — what changed since Replied, post #100 · Lounge › Off topic · 14 Jul 2026 · 7 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Follow-up: Reading an interaction checker output critically Replied, post #39 · Practice › Interactions · 9 Jul 2026 · 0 likes Picking up post #38: that is the part I would want checked first. Gastrointestinal symptoms from one compound can mask or mimic an interaction with another. Introducing…
-
Asking a follow-up: new topic or new reply? Replied, post #40 · Start Here › How to Ask · 6 Jul 2026 · 13 likes Edit the first post rather than adding the missing detail in reply nine. People arriving later read the first post and stop. I would want the raw data before agreeing…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #16 · Evidence › Preprints · 5 Jul 2026 · 2 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #57 · Evidence › Journal club · 4 Jul 2026 · 3 likes Where I would push back on the STEP 1 consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Revisiting: The best-written scientific paper you have read Replied, post #54 · Lounge › Off topic · 26 Jun 2026 · 0 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
How shortages have affected compounding permissions Started this topic · Access › Shortages · 26 Jun 2026 · 27 likes How shortages have affected compounding permissions I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to know what…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #80 · Start Here › Welcome · 23 Jun 2026 · 12 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #50 · Analytics › Impurities & related substances · 18 Jun 2026 · 20 likes I had written a reply contradicting post #48 and deleted it. Here is what survived. Where I have landed on Endotoxin, having got it wrong once in public: the direction…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #40 · Evidence › Journal club · 17 Jun 2026 · 26 likes The most useful reply I ever got about SURMOUNT-OSA was a request to state my units. It sounds like pedantry and it has saved me twice.
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #106 · Practice › Reconstitution · 13 Jun 2026 · 8 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Second-hand,…
-
Revisiting: The best-written scientific paper you have read Replied, post #21 · Lounge › Off topic · 8 Jun 2026 · 29 likes Something I have wondered without ever asking: is there a good reason the vocabulary in this field is so inconsistent between suppliers? Half the disagreements here…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #41 · Practice › Storage & stability · 1 Jun 2026 · 1 like The honest summary: keep it dry until you need it, keep it cold once it is not, keep it dark, do not cycle the temperature, and treat any period at room temperature as…
-
What published stability data actually covers, and what it does not Replied, post #4 · Practice › Storage & stability · 31 May 2026 · 26 likes What I want from this published stability data actually covers thread is the list of things that would need to be true for the claim to hold. If we can write that list,…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #18 · Compounds › Secretagogues & GH axis · 31 May 2026 · 11 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
-
Prescription requirements and telehealth models — a second dataset Replied, post #43 · Sourcing › Regulatory · 27 May 2026 · 0 likes What I would tell a new member reading about Prescription requirements and telehealth models for the first time: the confident posts are not the reliable ones, and the…
-
Second pass at: Temperature logging at home: what is worth the effort Replied, post #7 · Practice › Storage & stability · 17 May 2026 · 0 likes Cold-chain arrival condition is worth recording even when everything is fine, because the record is only useful if it contains the ordinary cases as well as the bad…
-
Reading a trial's population section before its results Replied, post #26 · Evidence › Trials · 16 May 2026 · 18 likes Saving this. It is the version I will quote when the question comes round again.
-
Forced degradation studies: designing one that is informative Replied, post #52 · Analytics › Method validation · 9 May 2026 · 0 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #14 · Practice › Dosing & titration · 7 May 2026 · 3 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #117 · Practice › Reconstitution · 29 Apr 2026 · 22 likes Worth separating two things that post #115 runs together. My position on Foaming during reconstitution is current rather than settled. I have revised it once already…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #50 · Evidence › Journal club · 29 Apr 2026 · 13 likes One more thing on orforglipron phase 2 that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the…
-
Second pass at: What a 2 ppm match establishes, and what it does not Replied, post #7 · Analytics › Mass spectrometry · 26 Apr 2026 · 22 likes Resolution: "high resolution" commonly means
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #130 · Practice › Reconstitution · 26 Apr 2026 · 27 likes Worth separating two things that post #128 runs together. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #17 · Practice › Reconstitution · 18 Apr 2026 · 10 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
List price versus negotiated price versus what you pay Replied, post #114 · Access › Pricing · 17 Apr 2026 · 6 likes Comparing a licensed product's price to a research-use-only preparation's price is comparing two different things, and the difference is most of the explanation. A…
-
List price versus negotiated price versus what you pay Replied, post #98 · Access › Pricing · 16 Apr 2026 · 10 likes Post #95 answers the question as asked. The question underneath it is different. The number people quote for list price versus negotiated price is a central estimate…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #64 · Start Here › Welcome · 10 Apr 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Grapefruit: why this class is not the class that cares Replied, post #112 · Practice › Interactions · 2 Apr 2026 · 22 likes Confirming post #109 from a second method, which matters more than confirming it from a second person. Alcohol: no absolute contraindication but it raises…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #73 · Practice › Reconstitution · 23 Mar 2026 · 5 likes On Foaming during reconstitution, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #114 · Access › Pricing · 13 Mar 2026 · 5 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #32 · Lounge › Introductions · 10 Mar 2026 · 0 likes There is: the practice category, and the calculators, both written for exactly that. Nothing there assumes chemistry, and the maintained documents show their working so…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #62 · Data & Tools › Calculators · 3 Mar 2026 · 0 likes I read post #58 twice before replying, because I had assumed the opposite. A calculator that shows its working is worth ten that give an answer. The whole value is…
-
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #48 · Research Methods › N-of-1 designs · 22 Feb 2026 · 6 likes Multiple outcomes measured without a primary one means something will move. Nominate the primary in advance and report the rest as secondary. The literature is thinner…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #65 · Start Here › How to Ask · 19 Feb 2026 · 7 likes Answering the question post #63 raises rather than the one it answers. Avoid "any advice?" at the end. It is so generic that people do not know which part of the post…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #94 · Documentation › Wiki requests · 17 Feb 2026 · 31 likes Request a new maintained page: if a question recurs, has a good marked solution, and contains a worked example, it is a candidate for promotion to a maintained…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #37 · Practice › Reconstitution · 17 Feb 2026 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #37 · Sourcing › Logistics · 12 Feb 2026 · 4 likes Coming back to post #35, because the follow-up matters more than the original answer. Document outcomes rather than forecasting them. A forecast in this category reads…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #5 · Access › Pricing · 11 Feb 2026 · 3 likes I would put moderate confidence on the mainstream reading of manufacturer assistance programmes and no more. That is not scepticism for its own sake; it is where the…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #24 · Outcomes › Progress reports · 9 Feb 2026 · 2 likes Worth separating two things that post #22 runs together. On Seven-day rolling: the maintained page in the documentation commons covers the general case with citations…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #13 · Practice › Administration · 27 Jan 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. A…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #42 · Devices › Pens & autoinjectors · 11 Jan 2026 · 11 likes That is the distinction I keep failing to hold on to. Written down now.
-
Guidelines revision: what changed and why — one year on Replied, post #56 · Meta › Announcements · 9 Jan 2026 · 26 likes Confirming post #54 from a second method, which matters more than confirming it from a second person. The version of Guidelines revision that I was taught turned out to…
-
Aggregates and why a purity assay may miss them entirely Replied, post #52 · Analytics › Impurities & related substances · 5 Jan 2026 · 25 likes I have no financial interest in anything named in this thread and I want to say so before I comment on aggregates, because it is the sort of subject where it matters.
-
Waist circumference technique and its repeatability Replied, post #31 · Outcomes › Progress reports · 26 Dec 2025 · 14 likes Taking post #30 at face value and following it one step further. Small correction to my own earlier position on waist circumference technique. I had the units the wrong…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #49 · Sourcing › Vendor reports · 24 Dec 2025 · 10 likes Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into something checkable. I would hold that lightly until someone…
-
Personal import allowances, compared Replied, post #10 · Access › International · 22 Dec 2025 · 10 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
DXA precision and the least significant change for lean mass Replied, post #79 · Outcomes › Body composition · 17 Dec 2025 · 0 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #25 · Sourcing › Regulatory · 17 Dec 2025 · 0 likes Post #24 describes the usual case. This is about the unusual one. If you can confirm or contradict a position for your own region, please date the answer. An undated…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #6 · Practice › Reconstitution · 9 Dec 2025 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Availability by country, dated, with primary sources Replied, post #73 · Access › International · 23 Nov 2025 · 0 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #6 · Compounds › Oral incretins · 12 Nov 2025 · 22 likes Worth separating two things that post #4 runs together. PIONEER programme is phase 3 for oral semaglutide. The trials cover multiple indications and durations. Reading…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #25 · Analytics › Method validation · 11 Nov 2025 · 4 likes Picking up post #24: that is the part I would want checked first. The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can…
-
Anxiety in the first weeks: drug, situation, or both — what changed since Replied, post #44 · Wellbeing › Mental health · 31 Oct 2025 · 21 likes Offering a way to settle Anxiety rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the noise,…
-
Payment mechanics and the recovery options that do not exist Replied, post #69 · Sourcing › Payments · 22 Oct 2025 · 3 likes Recurring billing: if a supplier sets up recurring billing by default, understanding the terms for cancellation is important before the first charge.
-
About the North America category Replied, post #6 · Regional › North America · 13 Oct 2025 · 10 likes Nothing in this subcategory is medical or legal advice, and the clinicians posting here say so on their own account. Anyone who has looked at this more carefully,…
-
A 40-week log with the measurement method stated Replied, post #2 · Outcomes › Progress reports · 11 Oct 2025 · 20 likes Whatever the answer on 40-week log turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
An inter-laboratory comparison on one lot, tabulated Replied, post #3 · Analytics › Method validation · 3 Oct 2025 · 1 like Validation is compound-specific and matrix-specific. A method validated for one peptide is a starting point for another and not a validated method for it.
-
Titles that describe the question, not the situation — what changed since Replied, post #15 · Start Here › How to Ask · 14 Sep 2025 · 2 likes Worth separating two things that post #13 runs together. If the answer you got does not fit your case, say which part does not fit rather than restating the question.…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #14 · Start Here › How to Ask · 12 Sep 2025 · 3 likes If the answer you got does not fit your case, say which part does not fit rather than restating the question. Otherwise the next reply is the same as the last one.
-
Tracking that stops updating and then resumes Replied, post #25 · Sourcing › Logistics · 9 Sep 2025 · 0 likes Post #24 is right about the mechanism and I think understates the practical bit. Document outcomes rather than forecasting them. A forecast in this category reads as…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #48 · Data & Tools › Datasets · 8 Sep 2025 · 0 likes Post #45 is right about the mechanism and I think understates the practical bit. Temporal bias: older data in a dataset might reflect conditions (supplier, formulation,…
-
An emergency department visit, described afterwards Replied, post #63 · Safety › Adverse events · 6 Sep 2025 · 6 likes Allergic-type reactions with breathing difficulty or swelling are an emergency rather than a topic, and this subcategory says so in its own guidance. That is one…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #14 · Evidence › Journal club · 4 Sep 2025 · 28 likes Coming back to post #10, because the follow-up matters more than the original answer. Adding what did not work for me on step-hfpef and symptom endpoints, since the…
-
Tirzepatide molecular mass and the charge states you would expect on ESI Started this topic · Compounds › Tirzepatide · 22 Aug 2025 · 2 likes Tirzepatide molecular mass and the charge states you would expect on ESI Writing it up because I had to work it out twice and would rather nobody else did. Tirzepatide…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #8 · Compounds › Semaglutide · 16 Aug 2025 · 0 likes Marking my place. If it changes for me I will come back and say so.
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #108 · Compounds › Semaglutide · 8 Aug 2025 · 19 likes A note on scope: what I am saying about Semaglutide half-life applies to the case in the first post and I would not extend it further without checking.
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #25 · Compounds › Oral incretins · 7 Aug 2025 · 18 likes Summarising the SOUL trial and oral semaglutide thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction…
-
How to research a compound with no human data without deceiving yourself Replied, post #26 · Compounds › Other compounds · 31 Jul 2025 · 1 like Research a compound is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #14 · Compounds › Secretagogues & GH axis · 26 Jul 2025 · 1 like On analysis: these are short peptides and generally straightforward chromatographically, which means a poor purity result is more likely to reflect the synthesis than…
-
Canadian access and provincial variation — one year on Replied, post #3 · Regional › North America · 18 Jul 2025 · 2 likes The opening post and I disagree about the size of the effect, not about the direction. The useful distinction on Canadian access and provincial variation is between…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #135 · Compounds › Tirzepatide · 13 Jul 2025 · 0 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
What this community means by "a source", in practical terms Replied, post #29 · Start Here › Welcome · 9 Jul 2025 · 11 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #62 · Compounds › Repair & healing peptides · 8 Jul 2025 · 1 like Summarising the TB-500 and thymosin beta-4 thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to…
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #44 · Sourcing › Regulatory · 7 Jul 2025 · 15 likes Practical experience of compound being unapproved, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #77 · Practice › Storage & stability · 2 Jul 2025 · 2 likes This is the sort of exchange that makes the archive worth searching.
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #16 · Practice › Reconstitution · 25 Jun 2025 · 1 like Thank you for the correction. I would rather find out here than later.
-
Triple agonism: additive, synergistic, or neither? Replied, post #58 · Compounds › Retatrutide · 18 Jun 2025 · 0 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #98 · Access › Insurance & coverage · 13 Jun 2025 · 10 likes Reading back through the appeal threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That seems…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #130 · Practice › Reconstitution · 9 Jun 2025 · 18 likes The arithmetic in post #129 is right; the assumption feeding it is the part to check. Concentration is total mass divided by total volume, and everything else follows…
-
Half-life, steady state, and accumulation worked through Replied, post #74 · Pharmacology › Pharmacokinetics · 6 Jun 2025 · 28 likes No disagreement from me. Posting only so the question does not look ignored.
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #59 · Compounds › Retatrutide · 3 Jun 2025 · 20 likes Post #56 answers the question as asked. The question underneath it is different. Having read the whole Retatrutide mass and identity thread before replying: the…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #8 · Analytics › Method validation · 3 Jun 2025 · 1 like Confirming post #7 from a second method, which matters more than confirming it from a second person. Forced degradation under acid, base, oxidation, heat and light is…
-
High-resolution MS on aggregates and what it can see Started this topic · Analytics › Mass spectrometry · 31 May 2025 · 1 like Posting this under the heading it deserves: High-resolution MS on aggregates and what it can see Everything below is what sits behind that. Something about…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #20 · Evidence › Journal club · 30 May 2025 · 13 likes The useful distinction on CagriSema phase 2 combination paper is between what was measured and what was inferred from it. Both end up in the same sentence and only one…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #66 · Compounds › Secretagogues & GH axis · 20 May 2025 · 5 likes Where I would push back on the Tesamorelin consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
-
Pregnancy as an absolute contraindication Replied, post #83 · Safety › Contraindications · 20 May 2025 · 12 likes Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #10 · Clinical › Special populations · 17 May 2025 · 23 likes Where I part company with post #7, and it is a narrow parting. On History of disordered eating I would separate what is worth knowing from what is worth acting on. The…
-
HbA1c lag and what it can and cannot tell you at eight weeks Replied, post #17 · Clinical › Bloodwork · 14 May 2025 · 14 likes Glycaemic markers integrate over different periods. A point glucose and a longer-term marker disagreeing is not a contradiction; it is two different questions. It cost…
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #3 · Compounds › Secretagogues & GH axis · 13 May 2025 · 10 likes Agreed on all of that, and I have nothing to add to it.
-
Second pass at: Reading a combination trial: attributing effect to components Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 4 May 2025 · 12 likes Post #10 put the caveat in the right place and I want to underline it. Nausea appears in the amylin-analogue literature as it does in the incretin literature, and the…
-
An emergency department visit, described afterwards Replied, post #16 · Safety › Adverse events · 30 Apr 2025 · 0 likes Gallbladder symptoms during rapid weight loss are described in this class and are also associated with rapid weight loss generally. Both can be true. A partial answer,…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #37 · Data & Tools › Calculators · 27 Apr 2025 · 1 like Significant figures in the output should not exceed what the inputs support. A concentration calculated from a nominal vial mass is not known to four decimal places.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #111 · Documentation › Doc review · 17 Apr 2025 · 1 like I had written a reply contradicting post #109 and deleted it. Here is what survived. Where content is lifted from a topic, attribution should be in the document rather…
-
Carryover and the ghost peak from last week's standard Replied, post #79 · Analytics › HPLC & UHPLC · 11 Apr 2025 · 13 likes Where I part company with post #77, and it is a narrow parting. Before anything else: what was the gradient, and at what wavelength? Area percent at different…
-
Distinguishing a deletion sequence by mass alone — the long version Replied, post #13 · Analytics › Mass spectrometry · 7 Apr 2025 · 5 likes Worth separating two things that post #11 runs together. Resolution and mass accuracy are different specifications. An instrument can resolve two species and still…
-
Carryover and the ghost peak from last week's standard Replied, post #10 · Analytics › HPLC & UHPLC · 1 Apr 2025 · 12 likes I had written a reply contradicting post #8 and deleted it. Here is what survived. Carryover from a previous injection shows up as a small peak at the same retention…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #12 · Compounds › Oral incretins · 31 Mar 2025 · 12 likes That is clearer than the version I had in my head. Thank you.
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #139 · Analytics › COA interpretation · 29 Mar 2025 · 5 likes Narrowing post #136, because the general version has more than one answer. The practical version of Counter-ion form is three sentences long. The rigorous version is…
-
Telehealth prescribing models in the US Replied, post #77 · Regional › North America · 29 Mar 2025 · 23 likes Prior authorisation criteria are usually published by the payer and reading them before the appointment changes the outcome more than anything else does. Old habit: I…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #93 · Access › International · 11 Mar 2025 · 0 likes The bit of Cross-border purchase within that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #60 · Pharmacology › Receptor biology · 8 Mar 2025 · 15 likes Ghrelin receptor agonism drives growth hormone release in pulses and also increases appetite, which is the effect people most reliably report and least often want.…
-
Validating a method you did not develop — does this still hold? Replied, post #81 · Analytics › Method validation · 6 Mar 2025 · 20 likes Answering the question post #80 raises rather than the one it answers. Robustness: the method gives consistent results when minor parameters vary. Tested by…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #37 · Documentation › Doc review · 27 Feb 2025 · 14 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #29 · Analytics › COA interpretation · 26 Feb 2025 · 8 likes Adding the measurement that post #27 says would settle it. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #7 · Wellbeing › Mental health · 16 Feb 2025 · 19 likes Confirming post #6 from a second method, which matters more than confirming it from a second person. Adding a null result on history of disordered eating. I looked,…
-
Canadian access and provincial variation Replied, post #80 · Regional › North America · 11 Feb 2025 · 14 likes Picking up post #78: that is the part I would want checked first. Both are useful and different. The account tells you what happens in practice; the criterion tells you…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #86 · Evidence › Meta-analyses · 10 Feb 2025 · 0 likes I read post #84 twice before replying, because I had assumed the opposite. Number needed to treat from a meta-analysis: can be computed from the pooled estimate if the…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #84 · Data & Tools › Calculators · 9 Feb 2025 · 12 likes Building on post #81 rather than restating it. A saved calculation is worth more than a remembered one. Write down the inputs alongside the result, because the result…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #75 · Evidence › Meta-analyses · 8 Feb 2025 · 1 like Adding the boring version of Random versus fixed effects, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary…
-
Scheduled maintenance and what will be unavailable Replied, post #36 · Meta › Announcements · 7 Feb 2025 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Second pass at: Transit times by route, from a logged dataset Replied, post #3 · Sourcing › Logistics · 11 Jan 2025 · 8 likes Customs outcomes are not predictable at the level of an individual parcel. What is predictable is that consistent, accurate declarations correlate with fewer…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #19 · Compounds › Oral incretins · 4 Jan 2025 · 4 likes On variability: the between-person spread in exposure for oral semaglutide is wide enough that two people on the same dose can have quite different plasma…
-
Isotonicity and what happens when you get it wrong Replied, post #14 · Pharmacology › Formulation chemistry · 1 Jan 2025 · 23 likes If you are new and reading this thread for the answer to isotonicity: the answer is conditional, the conditions are in the third reply, and the rest of the thread is…
-
What we do not know about retatrutide, listed explicitly Replied, post #36 · Compounds › Retatrutide · 28 Dec 2024 · 0 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #13 · Analytics › Mass spectrometry · 28 Dec 2024 · 5 likes For a compound with no reference standard in circulation, an observed mass is much more useful than an assertion of agreement with a theoretical value nobody can check.
-
Body image changing more slowly than the body Replied, post #128 · Wellbeing › Mental health · 25 Dec 2024 · 14 likes Coming back to post #126, because the follow-up matters more than the original answer. Body image was covered in the wiki last year and the page has a review date on…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #7 · Compounds › Other compounds · 24 Dec 2024 · 0 likes Solubility varies far more across this subcategory than within the incretins. A compound that needs a specific diluent or a specific pH is not being difficult; it has a…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #49 · Sourcing › Regulatory · 22 Dec 2024 · 0 likes The most useful thing anyone has posted about Research-use-only labelling in this category was a table of what had been measured and by whom. That is what I would want…
-
Converting between mg/mL and units per dose, both directions Replied, post #139 · Practice › Reconstitution · 21 Dec 2024 · 0 likes The arithmetic in post #138 is right; the assumption feeding it is the part to check. Preservative effectiveness is tested against a defined microbial challenge under…
-
Body image changing more slowly than the body Replied, post #34 · Wellbeing › Mental health · 14 Dec 2024 · 0 likes Saving this. It is the version I will quote when the question comes round again.
-
Revisiting: Moderation log format change Replied, post #66 · Meta › Announcements · 13 Dec 2024 · 0 likes I came in to disagree and I am leaving without a disagreement.
-
Criticising the method without criticising the authors Replied, post #21 · Evidence › Study critique · 2 Dec 2024 · 0 likes Per-protocol and intention-to-treat analyses answer different questions and neither is the honest one by default. Reporting both is the practice worth insisting on.
-
Why "any advice?" is the least effective ending for a post Replied, post #74 · Start Here › How to Ask · 26 Nov 2024 · 16 likes Post #72 put the caveat in the right place and I want to underline it. Number your questions if there is more than one. It sounds fussy. It means the answer can be…
-
Type 1 diabetes: off-label use and the evidence gap — what changed since Replied, post #77 · Clinical › Special populations · 26 Nov 2024 · 30 likes The arithmetic in post #74 is right; the assumption feeding it is the part to check. On Type 1 diabetes, the part that usually goes wrong is that the question is asked…
-
Time to steady state after a dose increase Replied, post #142 · Pharmacology › Pharmacokinetics · 6 Nov 2024 · 26 likes The arithmetic in post #139 is right; the assumption feeding it is the part to check. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days.…
-
Transit times by route, from a logged dataset — the long version Replied, post #23 · Sourcing › Logistics · 24 Oct 2024 · 1 like I have been on both sides of the Transit times argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #75 · Clinical › Bloodwork · 2 Oct 2024 · 0 likes A trend needs at least three points to be a trend. Two points are a line and a line through noise is still a line. I would want a second opinion before relying on that.
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #32 · Compounds › Retatrutide · 12 Sep 2024 · 7 likes Reading rather than answering, but this is the post I would point somebody at.
-
How to ask for a dose change without antagonising anyone Replied, post #22 · Clinical › Prescriber conversations · 5 Sep 2024 · 0 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X.
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #29 · Sourcing › Independent verification · 1 Sep 2024 · 13 likes Verification records are dated because they expire in usefulness. A result from two years ago describes a lot from two years ago.
-
Promotion criteria, and the one that stops most nominations Replied, post #49 · Documentation › Doc review · 29 Aug 2024 · 1 like Everything in post #45 holds. The case it does not cover is the one I have. The most useful review comment names a sentence and says what is wrong with it. General…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #4 · Clinical › Special populations · 27 Aug 2024 · 0 likes Athletes and people in substantial training loads are effectively unstudied, and the questions asked here about performance have no trial evidence behind them at all.…
-
Reporting a discrepancy without making an allegation Replied, post #25 · Sourcing › Vendor reports · 13 Aug 2024 · 0 likes Nobody has said the unglamorous part of reporting a discrepancy yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
Circumference measurements as a poor man's composition estimate Replied, post #59 · Outcomes › Body composition · 11 Aug 2024 · 4 likes Post #57 and I disagree about the size of the effect, not about the direction. Circumference measurements at marked sites, taken consistently, track composition change…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #79 · Evidence › Journal club · 29 Jul 2024 · 1 like Post #76 and I disagree about the size of the effect, not about the direction. Reading order that works for these sessions: registry entry, methods, baseline table,…
-
Assessing a warm arrival: the decision process — one year on Replied, post #106 · Sourcing › Logistics · 1 Jun 2024 · 0 likes Assessing a warm arrival is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…